High demand encourages Sterling Pharma's phased expansion of its US facility28 Oct 2019
The investment will allow the CDMO to take on new projects, as well as bolster the company's chemistry development capabilities.
CDMO, Sterling Pharma Solutions, is investing $1.5 million into a phased expansion of its US facility in North Carolina.
The investment follows the acquisition of the former US CiVentiChem site earlier this year. Over the next 3 years, the company plans to expand the cGMP production suites, add a non-GMP scale-up production facility, expand its QC laboratory and increase the site’s R&D capacity.
Mat Minardi, President US Operations said: “The North American market now makes up 70% of our customer portfolio. And, having expanded our US presence earlier this year with the acquisition of our facility in North Carolina, we have continued to experience strong growth.
“This investment will allow us to continue to meet customer expectations and take on new projects, as well as bolster Sterling’s chemistry development capabilities.
“The specialist capabilities provided by Sterling, particularly our ability to handle challenging chemistries, are in high demand as a result of the increasing complexity of products entering the drug pipeline and the need for more efficient and cost-effective production of APIs. We’re confident this investment will be of huge benefit to our customers.”
The investment plan will also allow Sterling to expand its quality assurance (QA) team to provide more support for cGMP projects, increase its team of chemists and put measures in place to help it secure its US Drug Enforcement Administration (DEA) Schedule I manufacturing approval. This recruitment drive, along with the initial facility expansion, forms the first part of the phased investment.
The facility, located close to Research Triangle Park, supports the development and manufacturing requirements for pre-clinical and early phase clinical supply for volumes from millilitres up to 100-L batches. The team has expertise in medicinal chemistry services, including lead optimisation and parallel synthesis, cGMP analytical services to support testing and release, process development and small-scale API manufacturing.
This latest investment is part of Sterling’s ongoing growth strategy and follows the completion of the majority acquisition of Sterling Pharma Solutions by specialist European healthcare investor, GHO Capital this year.
As part of its expansion plans Sterling is also recruiting for its US BD and sales team.
Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD
21 Feb 2020
Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase.Read more
The game is on for connected devices
20 Feb 2020
Global biologics markets, delivery device innovation and smart packaging ‘unpacking’ new growth opportunities for pharma.Read more
Management healthcare consultancy opens new offices in New York and London
19 Feb 2020
The expansion will enable Putnam Associates to access the European market and to offer more localised support to its clients.Read more
CPhI South East Asia rescheduled for July 2020
18 Feb 2020
Event move ensures extra precautions and safety measures takenRead more
Sphere Fluidics expands to increase supply of surfactant for droplet microfluidics
18 Feb 2020
Investment in resources to meet demand for large-scale supply of patented biocompatible surfactant.Read more
Dr Reddy's to acquire Wockhardt divisions
18 Feb 2020
Deal sees 62 brands in multiple therapy areas and a manufacturing plant transfer to the companyRead more
Sartorius sharpens its brand focus
17 Feb 2020
The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster.Read more
FDA success for MedPharm Centre of Excellence
14 Feb 2020
The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.Read more
Report predicts booming ASEAN generics export market for 2020
13 Feb 2020
The changing opportunities are attributed to rising GMP standards and increased regional harmonization.Read more
Partnership formed to deliver effective biopharma industry testing
12 Feb 2020
Stevanato and Pfeiffer Vacuum will provide biopharma companies with advanced container closure integrity analysis and testing protocols.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation